Literature DB >> 15077032

Increased expression of nitric oxide synthase in human lung transplants after nitric oxide inhalation.

Jonathan A Cardella1, Shaf H Keshavjee, Xiao-Hui Bai, Jin-Soon Yeoh, John T Granton, Maureen O Meade, Andrea Matte-Martyn, Thomas K Waddell, Mingyao Liu.   

Abstract

BACKGROUND: The effects of the ischemia-reperfusion process of organ transplantation on nitric oxide (NO) synthase (NOS) in humans are unknown. The effects of NO inhalation on endogenous NOS expression and activity are controversial. The authors hypothesized that NO inhalation may affect ischemia-reperfusion-induced alterations of the endogenous NOS system.
METHODS: The authors performed lung biopsy on patients in a randomized phase II clinical trial of NO inhalation during lung transplantation. After lung implantation, 20 ppm of NO or placebo gas was administered 10 min after the start of reperfusion. Lung tissues were collected from 20 patients (NO, n=9; placebo, n=11) after cold and warm ischemia, 1 hr and 2 hr after reperfusion. The protein levels of NOS isoforms were analyzed by Western blotting and the total NOS activity was measured.
RESULTS: The protein levels of inducible NOS did not change significantly in either of the groups. In contrast, during the 2-hr reperfusion period, constitutive NOS (neuronal NOS [nNOS] and endothelial NOS) tended to decrease in the placebo group, but gradually increased in the NO group. After 2 hr of reperfusion, the nNOS protein in the NO group was significantly higher than that in the placebo group (P <0.05). However, the total NOS activity remained at low levels in both groups.
CONCLUSIONS: NO inhalation-induced increase of constitutive NOS proteins indicates the interaction between inhaled NO molecules and lung tissues. However, the activity of these newly synthesized NOS proteins remains suppressed during the ischemia-reperfusion period of lung transplantation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15077032     DOI: 10.1097/01.tp.0000118477.11722.a2

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Src tyrosine kinase inhibition prevents pulmonary ischemia-reperfusion-induced acute lung injury.

Authors:  Takeshi Oyaizu; Shan-Yu Fung; Atsushi Shiozaki; Zehong Guan; Qiao Zhang; Claudia C dos Santos; Bing Han; Marco Mura; Shaf Keshavjee; Mingyao Liu
Journal:  Intensive Care Med       Date:  2012-02-17       Impact factor: 17.440

2.  A physiologic and biochemical profile of clinically rejected lungs on a normothermic ex vivo lung perfusion platform.

Authors:  Timothy J George; George J Arnaoutakis; Claude A Beaty; Simran K Jandu; Lakshmi Santhanam; Dan E Berkowitz; Ashish S Shah
Journal:  J Surg Res       Date:  2012-11-27       Impact factor: 2.192

Review 3.  Inflammatory response to pulmonary ischemia-reperfusion injury.

Authors:  Calvin S H Ng; Song Wan; Ahmed A Arifi; Anthony P C Yim
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

4.  The early responses of VEGF and its receptors during acute lung injury: implication of VEGF in alveolar epithelial cell survival.

Authors:  Marco Mura; Bing Han; Cristiano F Andrade; Rashmi Seth; David Hwang; Thomas K Waddell; Shaf Keshavjee; Mingyao Liu
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

5.  Ventilator-induced lung injury and mechanotransduction: why should we care?

Authors:  Mingyao Liu
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.